Shi MQ - Search Results

1

Lack of influence of XRCC1 and XPD gene polymorphisms on outcome of platinum-based chemotherapy for advanced non small cell lung cancers.

Yao CY, Huang XE, Li C, Shen HB, Shi MQ, Feng JF, Pan LX, Tang JH. Yao CY, et al. Among authors: shi mq. Asian Pac J Cancer Prev. 2009;10(5):859-64. Asian Pac J Cancer Prev. 2009. PMID: 20104979 Free article.

2

Polymorphisms of the ribonucleotide reductase M1 gene and sensitivity to platin-based chemotherapy in non-small cell lung cancer.

Feng JF, Wu JZ, Hu SN, Gao CM, Shi MQ, Lu ZH, Sun XC, Zhou JR, Chen BA. Feng JF, et al. Among authors: shi mq. Lung Cancer. 2009 Dec;66(3):344-9. doi: 10.1016/j.lungcan.2009.02.015. Epub 2009 Mar 21. Lung Cancer. 2009. PMID: 19304340

3

[Prognostic significance of ERCC1 mRNA expression in patients with non-small cell lung cancer receiving platinum-based chemotherapy].

Qian XP, Liu BR, Shi MQ, Liu XZ, Hu WJ, Zou ZY, Wei J. Qian XP, et al. Among authors: shi mq. Zhonghua Zhong Liu Za Zhi. 2009 Jan;31(1):33-7. Zhonghua Zhong Liu Za Zhi. 2009. PMID: 19538866 Chinese.

4

Predictive value of ERCC1 and XPD polymorphism in patients with advanced non-small cell lung cancer receiving platinum-based chemotherapy: a systematic review and meta-analysis.

Wei SZ, Zhan P, Shi MQ, Shi Y, Qian Q, Yu LK, Song Y. Wei SZ, et al. Among authors: shi mq, shi y. Med Oncol. 2011 Mar;28(1):315-21. doi: 10.1007/s12032-010-9443-1. Epub 2010 Feb 9. Med Oncol. 2011. PMID: 20143185 Review.

5

Weekly paclitaxel/ docetaxel combined with a platinum in the treatment of advanced non-small cell lung cancer: a study on efficacy, safety and pre-medication.

Zhou JN, Huang XE, Ye Z, Li C, Zhang Q, Lin Y, Jiang W, Sunh WL, Shi MQ, Shu YQ. Zhou JN, et al. Among authors: shi mq. Asian Pac J Cancer Prev. 2009;10(6):1147-50. Asian Pac J Cancer Prev. 2009. PMID: 20192601 Free article.

6

[A randomized, prospective, multi-centre clinical trial of NP regimen (vinorelbine+cisplatin) plus Gensing Rg3 in the treatment of advanced non-small cell lung cancer patients].

Sun Y, Lin H, Zhu Y, Feng J, Chen Z, Li G, Zhang X, Zhang Z, Tang J, Shi M, Hao X, Han H. Sun Y, et al. Zhongguo Fei Ai Za Zhi. 2006 Jun 20;9(3):254-8. doi: 10.3779/j.issn.1009-3419.2006.03.09. Zhongguo Fei Ai Za Zhi. 2006. PMID: 21172156 Free article. Chinese.

7

[Genetic polymorphisms in methylenetetrahydrofolate reductase and clinical response to chemotherapy in non-small cell lung cancer].

Shi M, Gao C, Wu J, Feng J, Cao H, Lu J, Xu L. Shi M, et al. Zhongguo Fei Ai Za Zhi. 2006 Dec 20;9(6):519-24. doi: 10.3779/j.issn.1009-3419.2006.06.09. Zhongguo Fei Ai Za Zhi. 2006. PMID: 21182814 Free article. Chinese.

8

Use of CT-guided fine needle aspiration biopsy in epidermal growth factor receptor mutation analysis in patients with advanced lung cancer.

Zhuang YP, Wang HY, Shi MQ, Zhang J, Feng Y. Zhuang YP, et al. Among authors: shi mq. Acta Radiol. 2011 Dec 1;52(10):1083-7. doi: 10.1258/ar.2011.110150. Epub 2011 Oct 17. Acta Radiol. 2011. PMID: 22006985

9

Correlation between polymorphisms of nicotine acetylcholine acceptor subunit CHRNA3 and lung cancer susceptibility.

Shen B, Shi MQ, Zheng MQ, Hu SN, Chen J, Feng JF. Shen B, et al. Among authors: shi mq. Mol Med Rep. 2012 Dec;6(6):1389-92. doi: 10.3892/mmr.2012.1101. Epub 2012 Sep 26. Mol Med Rep. 2012. PMID: 23023782

10

CHRNA5 polymorphism and susceptibility to lung cancer in a Chinese population.

Shen B, Zhu Q, Zheng MQ, Chen J, Shi MQ, Feng JF. Shen B, et al. Among authors: shi mq. Braz J Med Biol Res. 2013 Jan;46(1):79-84. doi: 10.1590/1414-431x20122451. Epub 2013 Jan 11. Braz J Med Biol Res. 2013. PMID: 23314339 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

125 results

Search Page

Filters